🇺🇸 OPKO HEALTH, INC.OPK

Company Update Form 8-K 15-10-2026 16:07:51 EDT

Subject: 8-K Items 1.01, 9.01

Overview: Entered into an agreement to sell BioReference’s pathology testing business to Laboratory Corporation of America Holdings for $722,000,000 in cash plus potential earnouts.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest